Related Experiment Video
Updated: Jun 3, 2026
06:47
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
The apolipoprotein e antagonistic pleiotropy hypothesis: review and recommendations
Elizabeth R Tuminello1, S Duke Han
1Department of Psychology, Loyola University Chicago, Chicago, IL 60660, USA.
International Journal of Alzheimer'S Disease
|March 23, 2011
Summary
The apolipoprotein E (APOE) ε4 allele may benefit cognition in youth but increase Alzheimer's disease risk later in life. This study reviews evidence for APOE's antagonistic pleiotropy across the lifespan.
Area of Science:
- Evolutionary biology
- Neuroscience
- Genetics
Background:
- The apolipoprotein E (APOE) ε4 allele is a known risk factor for Alzheimer's disease (AD).
- Emerging research suggests APOE ε4 may offer benefits in younger individuals, with risks appearing later in life.
- This pattern aligns with the concept of antagonistic pleiotropy, where alleles have differing effects across life stages.
Purpose of the Study:
- To critically evaluate the antagonistic pleiotropy hypothesis of APOE.
- To synthesize new research on APOE's impact on cognition and neural integrity throughout life.
- To propose revisions to the APOE antagonistic pleiotropy hypothesis and identify future research directions.
Main Methods:
- Literature review of studies investigating APOE genotype, cognition, and neural integrity across the lifespan.
- Critical analysis of existing research through the lens of evolutionary biology and antagonistic pleiotropy.
- Synthesis of findings to re-evaluate the proposed APOE antagonistic pleiotropy model.
Main Results:
- Evidence supports a dual role for APOE ε4, potentially enhancing cognitive function in youth.
- The APOE ε4 allele is consistently linked to increased risk of cognitive decline and Alzheimer's disease in later life.
- The findings necessitate a nuanced understanding of APOE's lifelong effects, moving beyond a simple risk factor model.
Conclusions:
- The antagonistic pleiotropy hypothesis provides a valuable framework for understanding APOE's complex role in aging and neurodegeneration.
- Further research is needed to refine the hypothesis, particularly regarding the molecular mechanisms underlying APOE ε4's differential effects.
- Revised models should incorporate lifespan trajectories of cognitive and neural health in relation to APOE genotype.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
02:41Lethal Alleles
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...